West Boylston, MA, United States of America

Jeffrey W Voss

This inventor holds 7 USPTO granted patents. Top assignees: Basf Aktiengesellschaft, Knoll Aktiengesellschaft, Abbott Gmbh & Co Kg. Active years: 1997-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey W Voss. Retrieved from https://idiyas.com/inventor/jeffrey-w-voss-llzm27w7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.5

ph-index = 7

Forward Citations = 228(Granted Patents)


Location History:

  • Framingham, MA (US) (1997 - 1999)
  • West Boylson, MA (US) (1999)
  • West Boylston, MA (US) (1997 - 2004)

Company Filing History:


Years Active: 1997-2004

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations in Gene Regulation: The Contributions of Jeffrey W. Voss

Introduction

Jeffrey W. Voss, an accomplished inventor located in West Boylston, MA, has made significant contributions to the field of gene regulation. With a portfolio of seven patents, Voss has focused on advancing methodologies that enhance the manipulation of gene expression in eukaryotic cells.

Latest Patents

Among Voss's recent patents are groundbreaking methods for regulating gene expression. One notable patent details a method for controlling the expression of a tet operator-linked gene within a subject's cells. This method involves introducing a nucleic acid molecule that encodes a tetracycline-controllable transactivator (tTA) into the cells. By modulating tetracycline concentrations, either through direct administration or by obtaining modified cells from the subject, the expression of desired genes can be reliably controlled.

Another patent focuses on the creation of transgenic organisms that incorporate a unique transcriptional regulatory system. These organisms carry dual transgenes—one coding for a transactivator fusion protein, and the other linked to a minimal promoter and tet operator sequence. This innovation proves essential for regulating gene expression conditional on tetracycline availability. Voss's isolated DNA molecules provide vital tools for integrating these sequences at specific genomic locations via homologous recombination, paving the way for sophisticated genetic research.

Career Highlights

Throughout his distinguished career, Jeffrey W. Voss has collaborated with prominent companies such as BASF Aktiengesellschaft and Knoll Aktiengesellschaft. His work has propelled forward the application of genetic engineering techniques, significantly influencing advancements in biotechnology and life sciences.

Collaborations

Voss has worked closely with esteemed colleagues Hermann Bujard and Manfred Gossen, contributing to the development of cutting-edge technologies in gene regulation. These collaborations have enhanced the quality and breadth of his research, leading to substantial innovations within the field.

Conclusion

Jeffrey W. Voss stands out as a pioneering inventor whose work in gene regulation continues to shape the landscape of biotechnology. His seven patents reflect a deep commitment to advancing science and technology, offering valuable tools for researchers and the potential for therapeutic applications that could benefit society at large.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…